About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COVID-19 in Patients With Chronic Liver Diseases

NCT04439084·23 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Stanford University

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Confirmed diagnosis of COVID-19
Personal history of either
* Chronic hepatitis C
* Chronic hepatitis B
* Alcoholic liver disease
* Non alcoholic liver disease
* Autoimmune hepatitis, Primary biliary cholangitis, Primary sclerosing cholangitis
* Cryptogenic cirrhosis
* Hepatocellular carcinoma

You may not be if

Non-COVID-19 patient

The record

StatusCompleted

PhaseNo phase

Taking part1,025

StartedMar 2020

UpdatedAug 9, 2021

Conditions

COVID-19 Chronic Liver Disease

Where23

University of Arizona,
Phoenix, Arizona, United States
Mayo Clinic
Scottsdale, Arizona, United States
UCSF Fresno
Fresno, California, United States

Clareo Health | COVID-19 in Patients With Chronic Liver Diseases